ClinicalTrials.govpublic full text
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
stomach neoplasms, digestive system neoplasms, neoplasms, digestive system diseases, stomach diseases, neoplasms by site, gastric cancer, neoadjuvant chemoimmunotherapy, neoadjuvant immunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892616
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.